Codexis(US:CDXS) ZACKS·2025-11-07 02:01分组1 - Codexis reported a quarterly loss of $0.22 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.15, and an improvement from a loss of $0.29 per share a year ago, indicating an earnings surprise of -46.67% [1] - The company posted revenues of $8.6 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 53.96%, and down from $12.83 million in the same quarter last year [2] - Codexis shares have declined approximately 54.9% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.10 on revenues of $23.61 million, and for the current fiscal year, it is -$0.67 on revenues of $65.14 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 41% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]